Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01273220 · ClinicalTrials.gov registry record
National Epidemiologic Survey on Alcohol and Related Conditions-III
A clinical trial, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- 36,309
- Enrollment target
NCT01273220: Completed study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
NCT01273220 is a clinical trial that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 36,309 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01273220 has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- 36,309 participants
- Enrollment target
Study Summary
Background: \- Alcohol use disorders are the most prevalent mental disorders in the United States and are a factor in more than 10 percent of all deaths, including heart disease, stroke, and certain types of cancer and chronic illness. Research into better treatment methods for alcohol use disorders and their associated disabilities requires a broad amount of information on the genetic and environmental factors that predispose certain individuals to alcoholism. To improve the quality of available information for research, the National Institutes of Health is conducting a nationwide survey on alcohol use disorders and related physical and mental disabilities, and will collect genetic information through saliva samples. Objectives: \- To collect interview data and saliva samples from the U.S. civilian noninstitutionalized population, 18 years and older, in order to study the extent of and contributing factors to alcohol use and abuse in the United States. Eligibility: \- Individuals at least 18 years of age who do not live in institutions (i.e., prisons, inpatient mental hospitals) and who are willing to be interviewed in English, Spanish, and the four most commonly spoken Asian languages in the United States (e.g., Chinese, Korean). Design: * The study will involve three main components: an automated computer-assisted interview, an automated questionnaire, and the collection of a saliva sample. * Participants will be recruited through community through publically available U.S. Census Bureau files. * The interview and questionnaire will ask standardized questions related to personal history; alcohol use and possible disorders; symptoms scales of mood, anxiety, and eating conditions that frequently co-occur with alcohol and drug use disorders; tobacco, medicine and drug use and disorders; selected personality traits, including behavior; alcohol, drug, and mental health treatment utilization; and medical conditions related to alcohol consumption. * Participants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36,309 participants |
| Start Date | 2011-01-07 |
| Est. Completion | 2020-08-18 |
What the finished NCT01273220 record still lists
NCT01273220 is an observational study that tracks outcomes without assigning an intervention. Its 36,309 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01273220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01273220 about?
NCT01273220 is a clinical study titled "National Epidemiologic Survey on Alcohol and Related Conditions-III". Background: \- Alcohol use disorders are the most prevalent mental disorders in the United States and are a factor in more than 10 percent of all deaths, including heart disease, stroke, and certain types of cancer and chronic illness. Research into better treatment methods for alcohol use disorder...
What is the current status of trial NCT01273220?
This trial is currently completed. The enrollment target is 36,309 participants. The study started on 2011-01-07. Estimated completion is 2020-08-18.
Who is sponsoring clinical trial NCT01273220?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT05796505 · 37,122 participants · NA
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI